Telmisartan + Cilnidipine + Chlorthalidone Tablet: Quick Summary
Uses, benefits, side effects, dosage & important warnings
Medicine Name
Telmisartan + Cilnidipine + Chlorthalidone Tablet
Drug Class
Angiotensin II Receptor Blocker (ARB) + Calcium Channel Blocker + Thiazide-like Diuretic
Uses
Treatment of high blood pressure when combination therapy is specifically prescribed
Benefits
Helps lower blood pressure through complementary mechanisms: telmisartan blocks angiotensin II, cilnidipine relaxes blood vessels and chlorthalidone promotes sodium and water excretion
Side Effects
Dizziness, low blood pressure, increased urination, electrolyte changes, headache, fatigue and ankle swelling may occur
Common Strengths
Combination strengths vary by manufacturer and product; use only the prescribed strength
Dosage
Dose is individualized according to blood pressure, kidney function, electrolyte levels and response to treatment
How to Take
Take exactly as prescribed, preferably at the same time each day; diuretic-containing combinations are often taken earlier in the day
How It Works
Telmisartan blocks angiotensin II, cilnidipine relaxes blood vessels and chlorthalidone helps the kidneys remove excess sodium and water
Monitoring
Blood pressure, kidney function and electrolytes such as potassium and sodium may require monitoring
Important
Do not change the dose or stop treatment without medical advice, especially if the medicine has been prescribed for long-term blood-pressure control
📉 Low Blood Pressure Warning:
This combination can lower blood pressure significantly. Dizziness, weakness or fainting may occur, particularly when treatment is started, the dose is increased or dehydration occurs.
This combination can lower blood pressure significantly. Dizziness, weakness or fainting may occur, particularly when treatment is started, the dose is increased or dehydration occurs.
🧪 Electrolyte Warning:
Chlorthalidone can alter electrolyte levels, including potassium and sodium. Periodic blood tests may be recommended, particularly during long-term treatment or after dose changes.
Chlorthalidone can alter electrolyte levels, including potassium and sodium. Periodic blood tests may be recommended, particularly during long-term treatment or after dose changes.
🩺 Kidney Function Warning:
Telmisartan and chlorthalidone can affect kidney function in susceptible patients. Kidney function should be monitored when clinically appropriate, especially in people with kidney disease or dehydration.
Telmisartan and chlorthalidone can affect kidney function in susceptible patients. Kidney function should be monitored when clinically appropriate, especially in people with kidney disease or dehydration.
⚠️ Potassium Warning:
Telmisartan may increase potassium levels, while chlorthalidone may lower potassium levels. The overall effect varies between patients, so potassium levels may need to be checked by a healthcare professional.
Telmisartan may increase potassium levels, while chlorthalidone may lower potassium levels. The overall effect varies between patients, so potassium levels may need to be checked by a healthcare professional.
💧 Dehydration Warning:
Chlorthalidone increases urine production. Excessive fluid loss can cause dehydration, dizziness or low blood pressure. Seek medical advice if you develop significant weakness, persistent dizziness or reduced urination.
Chlorthalidone increases urine production. Excessive fluid loss can cause dehydration, dizziness or low blood pressure. Seek medical advice if you develop significant weakness, persistent dizziness or reduced urination.
🦶 Ankle Swelling Warning:
Cilnidipine may cause swelling of the ankles or feet in some patients. Inform your doctor if swelling is persistent, severe or worsening.
Cilnidipine may cause swelling of the ankles or feet in some patients. Inform your doctor if swelling is persistent, severe or worsening.
⚠️ NSAID Interaction:
NSAIDs such as ibuprofen, diclofenac and naproxen may reduce the blood-pressure-lowering effect of telmisartan and diuretics and may increase the risk of kidney problems in susceptible patients.
NSAIDs such as ibuprofen, diclofenac and naproxen may reduce the blood-pressure-lowering effect of telmisartan and diuretics and may increase the risk of kidney problems in susceptible patients.
🤰 Pregnancy Warning:
Telmisartan should not be used during pregnancy because medicines that block the renin-angiotensin system can cause serious fetal harm. Contact your doctor immediately if pregnancy occurs.
Telmisartan should not be used during pregnancy because medicines that block the renin-angiotensin system can cause serious fetal harm. Contact your doctor immediately if pregnancy occurs.